Selected Grants
BEAT-MS
Clinical TrialPrincipal Investigator · Awarded by Immune Tolerance Network · 2020 - 2028A phase IV, prospective, multicenter, open-label, mothermilk study to evaluate ofatumumab concentration in the breast milk of lactating women with relapsing forms of multiple sclerosis receiving ofatumumab (Kesimpta ®
Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2024 - 2027MOGAD -
Clinical TrialPrincipal Investigator · Awarded by Genentech, Inc. · 2024 - 2026Rare Demyelinating Diseases and Pregnancy Outcomes: A Retrospective Cohort Study
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by Foundation of the Consortium of Multiple Sclerosis Centers · 2024 - 2025BEAT-MS
Clinical TrialPrincipal Investigator · Awarded by Benaroya Research Institute at Virginia Mason · 2021 - 2025ECHO MS
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Multiple Sclerosis Society · 2023 - 2024ACE Covid 19 Admin. Supplement: Molecular Regulation of B cells and T cells in Human SLE - Cost Reimbursable
Clinical TrialCo Investigator · Awarded by Emory University · 2021 - 2024Feasibility of the Multiple Sclerosis Performance Test for assessment of functional performance measures in patients with Multiple Sclerosis
Clinical TrialPrincipal Investigator · Awarded by Biogen, Inc. · 2019 - 2023Tablet Based Assessment of Cognition and Functional Capacity in MS
ResearchPrincipal Investigator · Awarded by VeraSci · 2020 - 2022External Relationships
- Novartis pharmaceuticals
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.